Gastroenterology6 Jul 2026
Upadacitinib, Infliximab Lead for Rapid Ulcerative Colitis ReliefRead article
Ophthalmology6 Jul 2026
Xiidra Leads Most Patients to 'Clinically Meaningful' Eye Dryness ReductionRead articleThe Life Science Feed
Deep dives with clinicians, researchers, and industry leaders.
All episodes
Alpha-Emitting Radioantibody Lowers PSA in CRPC
An investigational alpha-emitting radioantibody demonstrated a reduction in PSA levels in patients with castration-resistant prostate cancer (CRPC).
Lung NeoplasmsHalf of Older Adults With Metastatic Lung Cancer Receive No Systemic Treatment
A significant proportion of older adults diagnosed with metastatic non-small cell lung cancer receive no systemic treatment, highlighting a critical care gap.
EASL 2026: Liver and Spleen Elastography for Fibrosis Assessment
EASL 2026 will feature a Skills Learning Centre on liver and spleen elastography, highlighting its role in non-invasive fibrosis assessment.
CholestasisNearly 1 in 10 With Primary Biliary Cholangitis Have CKD
Chronic kidney disease affects 9.5% of patients with primary biliary cholangitis, with hypertension and older age driving incidence.
Fatty LiverLiver-Directed Treatment Shows Efficacy in Metabolic Dysfunction
A novel liver-directed treatment presented at endo 2026 offers a targeted approach for metabolic dysfunction, addressing a significant unmet clinical need.
Alcohol and Sugar: A Dual Metabolic Challenge for Patients
7 min readEASL 2026 Forum: Enhancing Patient-Clinician Communication
8 min readEASL Congress 2026: Key Trials to Watch in Liver Disease Management
7 min readEASL 2026: Alcohol Policy Action Needed for Liver Disease
7 min read
Novel Therapies Target Atherogenic Lp(a) Particle
Emerging therapeutic strategies are shifting focus from LDL cholesterol to apoB, targeting Lp(a) and other atherogenic particles.
Coronary Artery DiseaseVitamin K2 Supplementation May Curb Coronary Calcification
Evidence suggests vitamin K2 supplementation may reduce coronary artery calcification, a key marker of cardiovascular disease risk.
Aortic Valve StenosisAI-Assisted Fetal Echocardiography Improves Early CHD Detection
Artificial intelligence (AI) integration into fetal echocardiography improves early detection of congenital heart disease (CHD), including aortic stenosis.
ESC Cardio-Oncology 2026: Key Sessions and Anticipated Focus Areas
7 min readHypotension Linked to Increased Alzheimer's Disease Risk
7 min read5D MRI Halves Scan Time for Congenital Heart Disease Imaging
10 min readUniversal Heart Failure Definition Issued by Global Societies
10 min readClopidogrel and Omeprazole: Re-evaluating Concomitant Use Risk
7 min read
GLP-1 Nonresponders Often Underserved by Inadequate Dosing, Poor Adherence
Many patients labeled as GLP-1 nonresponders never receive optimal dosing or sufficient support for adherence, hindering therapeutic success.
Diabetes Mellitus Type 2Isaacs Emphasizes 'Human Touch' in Diabetes Care Beyond Technology
Diana Isaacs, PharmD, an ADA award winner, advocates for integrating empathetic, patient-centered approaches with advanced diabetes technology to improve outcomes.
ObesityHaaland's 6,000-Calorie Diet: Performance Fuel or Health Risk?
Erling Haaland's reported 6,000-calorie daily diet, while fueling elite athletic performance, presents significant long-term health considerations for the general population.
Elecoglipron Oral GLP-1 Reduces Glucose, Weight in Phase 2
11 min readFoundayo Confers Greater HbA1c Reduction Than Farxiga, Ozempic Pill in T2D
8 min readGLP-1s for Addiction: Are We There Yet?
10 min readUnapproved Retatrutide Use Challenges Clinicians
10 min readGLP-1 Agonists Show Ocular Safety, Potential Therapeutic Role
9 min read
Cognitive Rehabilitation Eases Long-COVID Brain Fog
Cognitive rehabilitation significantly improved brain fog symptoms in patients with long-COVID, offering a structured approach to managing persistent neurological sequelae.
Alzheimer DiseaseCreatine Supplementation: Limited Evidence for Brain Health Benefits
Creatine supplementation shows inconsistent and largely unproven benefits for brain health in healthy adults, with some promise in specific populations facing metabolic stress.
StrokeTBI Linked Bidirectionally With Psychiatric and Neurologic Conditions
Traumatic brain injury (TBI) shows a two-way association with various psychiatric and neurologic conditions, increasing risk for both and being influenced by their presence.
New Parkinson's Drug Offers Sustained Levodopa Levels
9 min readMigraine Linked to Increased Vascular Dementia Odds in Observational Data
11 min readHuntington's Disease Therapy Faces Regulatory Setbacks, Clinical Impact
10 min readEptinezumab Improves Cognitive Symptoms in Migraine Patients
13 min readDopamine Agonists: A Fading Role in Parkinson's Treatment?
9 min read
New Regimen Confers 'Meaningful' Benefit in Aggressive Lymphoma
7 min readFDA Expands Casgevy for Sickle Cell in Children 2 Years and Older
8 min readMonoclonal Antibodies May Complicate Transfusion Testing
7 min readBlood Transfusion Safety: Pathogen Inactivation Reduces Transfusion-Transmitted Infections
7 min readChemo-Free Therapy Improves Outcomes in Pediatric APL (EHA 2026)
8 min readPersonalized Hemophilia Care: EHA 2026 Highlights Individualized Approaches
7 min readMacrophages: Dual Role in Haematological Malignancies Explored
7 min readMolecular Hematology: From Gene Profiles to Therapy Profiles at EHA 2026
7 min readITP Management: Bridging Clinician and Patient Perspectives
7 min readCLL: Aligning Patient Priorities with Targeted Therapy at EHA 2026
8 min read
Sleep Disruption and Fear Drive Chronic Rheumatic Pain
11 min readPodcast: Why Cheaper Humira Alternatives Face Resistance
ListenPodcast: Stopping Spinal Fusion Or Protecting The Gut?
ListenPodcast: Chasing Absolute Zero In Rheumatoid Arthritis
ListenPodcast: The ORAL Surveillance JAK Inhibitor Controversy
Listen
Air Embolism: Two Cases After Percutaneous Lung Biopsy
7 min readSingle Question May Flag Poor Quality Sleep in Patients
9 min readPembrolizumab Reduces Pulmonary AEs vs Chemotherapy in NSCLC
8 min readDupilumab Superior to Omalizumab in High-Biomarker Asthma
7 min readATS 2026: NTM Lung Disease Detection, Therapy, QoL Advancements
8 min read
COVID Vaccine Efficacy in Children: A Review of Real-World Data
8 min readRifadin Syrup Under Review for Carcinogen Concerns
7 min readPublic Health Measures Significantly Reduced COVID-19 Incidence
8 min readData Integrity Concerns Raised in Pfizer's COVID-19 Vaccine Trial
7 min readVaccine Cold Chain Integrity Underpins Vaccine Security
8 min read
CAR T-Cell Therapy Nears Approval for Refractory Skin Diseases
7 min readTSW Controversy: Mitochondrial NAD Excess Identified, Diagnostic Clarity Emerges
9 min readPrior Authorization Delays Atopic Dermatitis Treatment Access
13 min readPatient-Reported Factors Redefine Alopecia Areata Severity
7 min readScalp Lesions: Rare Malignancies Mimic Benign Conditions
7 min readVariceal Bleeding Management: EASL 2026 Skills Centre Focuses on Endoscopic and Pharmacological Strategies
8 min readHeat-Attributable CVD Years of Life Lost Projected to Rise Through 2050
8 min readMedically Tailored Meals Cut HbA1c More Than Subsidies in Type 2 Diabetes
ML Model Predicts Epilepsy Onset in Depression, Depression in Epilepsy
9 min readBRINSUPRI® First Therapy Approved for NCFB at ATS 2026
7 min readCurrent and Emerging Therapies for Pulmonary Tuberculosis
6 min readDown Syndrome: Skin Conditions Demand Dermatologists’ Attention
7 min readWearable Devices Detect CAR-T CRS Hours Earlier, Improving Patient Outcomes
7 min readTucatinib Extends PFS in HER2-Positive Breast Cancer, No New Safety Signals
11 min readGiredestrant Improves Breast Cancer Survival Regardless of Menopause
8 min readProstate Care: Balancing Immediate Relief with Long-Term Retreatment
10 min readGenetic Test Identifies Breast Cancer Patients Who May Avoid Chemotherapy
12 min readBiomarkers and Novel Treatments Highlight Prostate Cancer Advances at ASCO
9 min read
Munich, DEAug 28 – 31UpcomingEASD 2026
Madrid, ESSep 9 – 12UpcomingERS 2026
Copenhagen, DKSep 12 – 15UpcomingESMO 2026Berlin, DESep 12 – 16UpcomingECTRIMS 2026Barcelona, ESSep 17 – 20UpcomingUEG Week 2026
Vienna, ATOct 3 – 7UpcomingAHA 2026
Chicago, USNov 7 – 9UpcomingACR 2026Washington DC, USNov 14 – 19UpcomingASH 2026New Orleans, USDec 12 – 15UpcomingACC.27 Together With WCCHouston, USApr 10 – 12PastENDO 2026Boston, USJun 13 – 16PastEHA 2026
Stockholm, SEJun 11 – 14PastEULAR 2026
London, GBJun 3 – 6PastASCO 2026Chicago, USMay 29 – Jun 2PastEASL 2026Barcelona, ESMay 27 – 30UpcomingESC 2026Munich, DEAug 28 – 31UpcomingEASD 2026Madrid, ESSep 9 – 12UpcomingERS 2026Copenhagen, DKSep 12 – 15UpcomingESMO 2026Berlin, DESep 12 – 16UpcomingECTRIMS 2026Barcelona, ESSep 17 – 20UpcomingUEG Week 2026Vienna, ATOct 3 – 7UpcomingAHA 2026Chicago, USNov 7 – 9UpcomingACR 2026Washington DC, USNov 14 – 19UpcomingASH 2026New Orleans, USDec 12 – 15UpcomingACC.27 Together With WCCHouston, USApr 10 – 12PastENDO 2026Boston, USJun 13 – 16PastEHA 2026Stockholm, SEJun 11 – 14PastEULAR 2026London, GBJun 3 – 6PastASCO 2026Chicago, USMay 29 – Jun 2PastEASL 2026Barcelona, ESMay 27 – 30
A-TANGO Score Refines ACLF Diagnosis, Prognosis in Cirrhosis
EULAR 2026: Polymyalgia Rheumatica Guidelines Incorporate RWE
ATS 2026: NTM Lung Disease Detection, Therapy, QoL Advancements
BTK Inhibitors in CLL: Evolving Landscape and Sequential Strategies
Endocrinologists' Role in Early Thyroid Eye Disease Recognition
AI in Hematology: EHA 2026 Focuses on Practical, Ethical Integration
SLE Pathophysiology Advances Inform Future Precision Care at EULAR 2026
Immuno-Fibrotic Crosstalk: A New Target in Rheumatology
Multimodal OSA Treatment: Nerve Stimulation, Surgery, Oral Appliances
Multidisciplinary Approach Improves Autoimmune ILD Management
Korlym® Improves Cushing's Syndrome Symptoms in Patient Experience Data
Desmopressin Dosing Refined for Central Diabetes Insipidus
AI, Wearables Transform Sleep Diagnostics: ATS 2026 Preview
Infection Prevention Critical in Hematological Malignancies
Optimising PsA and axSpA Treatment: EULAR 2026 Focuses on Early Intervention
Early Intervention Crucial for Inflammatory Joint Disease, Osteoporosis
CAR T Cell Therapy Shows Efficacy in Autoimmune Diseases at EULAR 2026
How Immunotherapy Unmasks Invisible Lung Cancer
Severe Hypoglycemia in T1D: Enhancing Patient-Clinician Dialogue
Hypercortisolism: Emerging Diagnostic and Management Insights
Evolving Infection Prevention in HSCT and Cellular Therapies
Triple Therapy Optimises COPD Outcomes at ATS 2026
Real-World Data Confirms Proximal Complement Inhibition in PNH
ASCO 2026 June 1st Program Highlights: Novel Immunotherapy Data
Acromegaly Management: Focus on Biochemical Control at ENDO 2026
ICI Dissemination Challenges Highlighted at ASCO 2026
ILD Diagnosis and Management: A Practical ATS 2026 Update
CD38 mAb Quad Therapy: Subcutaneous Dosing Reduces Burden
AI Algorithms Enhance Pulmonary Disease Management at ATS 2026
Macrophages: Dual Role in Haematological Malignancies Explored
BCMA-Directed Therapies Show Efficacy in Relapsed/Refractory Multiple Myeloma
NK Cell Immunotherapy: Biology to Clinic at AACR 2026
Biomarkers and Novel Treatments Highlight Prostate Cancer Advances at ASCO
JAK Inhibitor Combinations Show Efficacy in Myelofibrosis at EHA 2026
Immune Drivers in Autoimmune Cytopenias Inform Patient Care
Novel Biomarkers Improve Pediatric Solid Tumor Detection
ASCO 2026 May 31st Program Highlights: Focus on Novel Immunotherapies
Early ILD Recognition in SARD/SSc: Drivers of Progression and Workflow Solutions
Cancer Therapies Induce Lifespan Comorbidities: ACCR 2026 Review
SpA Remission: Clinical Symptoms vs. Subclinical Inflammation at EULAR 2026
Afirma Molecular Testing: Unique Situations and New Prognostic Development
DLBCL Relapse: EHA 2026 Addresses Gaps in Treatment Strategy
Autoantibodies: Hidden Drivers of Autoimmune Rheumatic Diseases
Pediatric Pulmonary Research Gaps Highlighted for Global Health
Acute Respiratory Failure: Lifespan Phenotypes and Trajectories
EASL 2026 Consensus: AATD-Liver Disease Management Standardised
EASL 2026: Non-invasive Diagnostics Advance Liver Disease Staging
EASL 2026 Forum: Enhancing Patient-Clinician Communication
HDV Management: EASL 2026 Highlights PegIFN-α as Standard
ITP Management: Bridging Clinician and Patient Perspectives
EASL 2026: Alcohol Policy Action Needed for Liver Disease
CAR T Cell Therapy Shows Promise in SLE and SSc Immune Reset
Novel Approaches Address Multiple Myeloma Resistance at EHA 2026
Novel Approaches in R/R MM: Expert Perspectives from EHA 2026
EULAR 2026: Earlier AxSpA Recognition Improves Disease Burden
YUTREPIA® (treprostinil) Inhalation Powder for PH-ILD Patients
Early AxSpA Diagnosis: Case-Based Discussion at EULAR 2026
Epithelial Dysfunction: A Unified Target in Airway Disease Management
JASCAYD® (nerandomilast) Offers New Therapeutic Option for COPD
Obesity Care: Tailored Treatment Strategies Highlighted at endo 2026
Low Alkaline Phosphatase: Recognizing Clinical Consequences
Lupus Management: Progress and Persistent Challenges at EULAR 2026
MCED Tests Show Promise for Earlier Cancer Detection at ASCO 2026
MLVs: Dual Role in Brain Metastases Offers Therapeutic Targets
Late-Onset Genetic Cholestasis: Underdiagnosis in Adults Examined
Rapid SLE Control Prevents Organ Damage: EULAR 2026 Focus
Inflammation Drives Sickle Cell Disease Pathophysiology
HER2-Expressing Breast Cancer: Advancements in Targeted Therapies
AI in Oncology: Practical Applications Transforming Cancer Care
Bispecific Antibodies Positioned in Relapsed Follicular Lymphoma
Defining Hyperphagia Treatment Possibilities in Prader-Willi Syndrome
Personalized Hemophilia Care: EHA 2026 Highlights Individualized Approaches
AML: Rethinking Intensive Therapy for Myelodysplasia-Related & Therapy-Related Subtypes
CPET Advances Refine Cardiopulmonary Disease Assessment at ATS 2026
Multiple Myeloma: Aligning Innovation with Clinical Practice at EHA 2026
IPF/PPF: Patient and Pulmonologist Perspectives Highlight Care Gaps
IDH1m AML: Ivosidenib Plus Azacitidine Improves OS by 12.5 Months
EULAR 2026: Psoriatic Disease Spectrum Highlights
Steroidogenesis Inhibitor Targets Root Cause of Cushing’s Syndrome
CD20-Targeted Therapies Remain Central to NHL Management
Multidisciplinary Care Improves Spondyloarthritis Outcomes
Pediatric Advanced Bronchoscopy: Precision in Airway Management
MASLD Diagnosis Faces Barriers Despite 2024 EASL Guidelines
TRUQAP + Fulvestrant: 2L Option for HR+/HER2- aBC/mBC with PI3K-AKT Alterations
CLL First-Line Treatment: BTK Inhibitors vs. Venetoclax Combinations
Cancer Care Disparities Highlighted in Crisis, Displaced Populations
AI Integration Improves Lung Cancer MDT Workflow at ATS 2026
PEAK Study Shows Novel Agent Improves PFS in Advanced GIST
AML: Fitness, Not Age, Predicts Intensive Chemotherapy Eligibility
DLBCL Treatment Sequencing: EHA 2026 Explores Current Therapies
Tile Radiation for Large Brain Mets: A New Approach at ASCO 2026
CAR T Therapy Shows Sustained Efficacy in Relapsed/Refractory Lymphoma
ATS 2026: Bronchiectasis and NTM Pulmonary Disease Management
Tafasitamab-R-CHOP Boosts Frontline DLBCL Outcomes at ASCO 2026
AATD: Aiming for AAT Restoration and Clinically Meaningful Endpoints
RA Care: Navigating Treatment Choices at EULAR 2026
Hypothyroidism: Symptom Burden Persists Despite Euthyroidism
Liver-Directed Treatment Shows Efficacy in Metabolic Dysfunction
12 Months of Romosozumab Builds Bone Density in Postmenopausal Osteoporosis
CAR T: Speed and Reliability Critical for Patient Outcomes
Cushing's Syndrome: Addressing Diagnostic Delays and Treatment Gaps
Desiccated Thyroid Extract: Efficacy and Safety in Hypothyroidism
Severe Asthma: Beyond Airway Focus in Treatment Decisions at ATS 2026
CELMoDs Show Promise in Relapsed/Refractory Multiple Myeloma
Optimising Transplant in Haemoglobinopathies: EHA 2026 Perspectives
Yoga Reduces Insomnia, Fatigue, Anxiety in Cancer Survivors
CLL First-Line Therapy: Case-Based Insights from EHA 2026
Belantamab Mafodotin's Evolving Role in RRMM: EHA 2026 Insights
Outsmarting Shape-Shifting Lung Cancer Resistance
CAR T in DLBCL: Optimising Patient Outcomes at EHA 2026
Tirzepatide: Efficacy in Weight Management Explored at ATS 2026
DNA Methylation Patterns Emerge as Sarcoma Biomarkers
Optimizing Frontline LR-MDS Treatment: EHA 2026 Data Review
Rare Conditions: EHA 2026 Highlights Diagnostic Challenges
GLP-1 RAs Reduce CV Risk in T2D Via Weight, Glucose Pathways
ANCA Vasculitis: Evolving Strategies Target Remission & Relapse Prevention
CLL: Aligning Patient Priorities with Targeted Therapy at EHA 2026
MASH Diagnosis: Non-Invasive Markers Show Promise at EASL 2026
AML Treatment Strategies: Optimising Outcomes in a Complex Disease
Few Pediatric Cancer Drugs Reach Phase 3 or Approval
AIRSUPRA® Reduces Asthma Exacerbations in ATS 2026 Data
Bispecific Antibodies Show Promise in Relapsed/Refractory Multiple Myeloma
Chemo-Free Therapy Improves Outcomes in Pediatric APL (EHA 2026)
Early Intervention in SLE/LN Reduces Long-Term Damage
Variceal Bleeding Management: EASL 2026 Skills Centre Focuses on Endoscopic and Pharmacological Strategies
Next-Gen Extracellular Vesicles: Biomarkers, Targets, Deliverables in Oncology
New 2L+ Combination Therapy Shows Efficacy in RRMM Post-PI/IMiD
Cancer Elimination at ASCO 2026: Aspirational Goals and Current Realities
EULAR 2026: Methotrexate Remains Cornerstone in RA First-Line
EASL Congress 2026: Key Trials to Watch in Liver Disease Management
More Breast Cancer Patients Can Skip Axillary Dissection
AAT Protein's Role in Lung Health Beyond COPD & Severe Asthma
HTAN Decodes Tumor Evolution: Ecological Perspective at AACR2026
Systemic Sclerosis: EULAR 2026 Highlights Diagnosis, Prognosis
Salivary Galectin-9 Elevated in Primary Sjögren's, Lacks Disease Activity Correlation
HYRNUO® (Sevabertinib) Shows Efficacy in Advanced Solid Tumours
Myriad's Precise MRD™ Test Shows Ultra-Sensitive Detection at ASCO 2026
EASL 2026: Liver and Spleen Elastography for Fibrosis Assessment
Oncodetect® MRD Test Shows Analytical Validity, Clinical Utility at ASCO
ATS 2026: Ultrasound Education Advances for Clinical Practice
XLH Adults: Osteomalacia Persists Despite Conventional Therapy
AML: Fitness, Not Age, Predicts IC Eligibility at EHA 2026
Molecular Hematology: From Gene Profiles to Therapy Profiles at EHA 2026
IKT-001 Adaptive Study Programme for Pulmonary Arterial Hypertension
DLBCL Management: Bispecific Antibodies as Emerging Therapeutic Option
Symptom Science Integration Improves Cancer Outcomes at ASCO 2026
Eosinophilic Disorders: Best Practices for HES and EGPA at ATS 2026
VEXAS Syndrome: Expert Consensus on Multidisciplinary Care at EULAR 2026
Endo 2026: Risk-Based Osteoporosis Management Refines Clinical Practice
EHA 2026: Anticipating Advances in Haematological Malignancies
New Biologic Offers Option for Severe Eosinophilic Asthma
RA Patients Face Elevated Fracture Risk: EULAR 2026 Highlights
CLL: EHA 2026 to Address Unmet Needs in Treatment Selection
ASCO 2026 May 29th Program Highlights: Novel Oncology Therapies
Iron Status Clarifies Erythrocytosis, Symptoms in Polycythemia Vera
Novel Therapies Improve Outcomes Post-cBTKi in CLL at EHA 2026
Radiopharmaceutical Therapy: Improving Effectiveness, Access, and Safety
EGPA: Early Recognition & Targeted Intervention Improve Outcomes
Inluriyo™ and Verzenio® Presentations at ASCO 2026
Sjögren’s Disease: Targeting Underlying Activity Beyond Symptoms
TACE + Camrelizumab/Rivoceranib Improves OS in Unresectable HCC
Hypoparathyroidism Treatment: Patient, Care Partner, HCP Perspectives
BRINSUPRI® First Therapy Approved for NCFB at ATS 2026
ATS 2026: Addressing the Cough Assessment Gap in Respiratory Disease
Epithelial Cytokines Link Severe Asthma, CRSwNP, COPD at ATS 2026
B-Cell Dysregulation Targeted Upstream in Primary Sjögren Disease
Triple Therapy in Asthma: Real-World Evidence Supports Earlier Use
EASL 2026: PSC Therapies Advance Beyond Symptom Management
Right Heart Catheterization: ATS 2026 Clarifies Waveform Interpretation
DLBCL Treatment: Emerging Targeted Therapies at EHA 2026
TLR7/8 Inhibition Offers New Lupus Perspective at EULAR 2026
Ventilator Management: Foundations for Bedside Implementation
IL-33's Dual Role in COPD: Inflammation and Mucus Dysfunction
Bispecific Antibodies in FL: EHA 2026 Explores Advancing Outcomes
Fixed-Duration BCL-2 Combo Offers Time Off Treatment in 1L CLL
Bronchoscopy Training: ATS 2026 Focuses on EBUS and Guided Techniques
Treat-to-Target in SLE: Balancing Burden, Benefit, and Risk
Contagion: Acute Respiratory Failure Cases Highlight Ventilator Management
ATS 2026: Lung Cancer Management Advances in Targeted Therapy
BCMA Bispecifics Transition to Community Myeloma Care: EHA 2026
Bispecific Antibodies Show Promise in Relapsed/Refractory Haematological Malignancies
MASH Advanced Fibrosis: Experts Detail Unique Challenges at EASL 2026
Immunotherapy and Targeted Therapy: New Data from ASCO 2026
MAVEs Inform Variant Interpretation in Clinical Oncology Practice
Caplacizumab Improves iTTP Outcomes in Real-World Settings
CD19+ B-Cell Targeting Shows Efficacy in IgG4-RD Management
ASCO 2026: Anticipating Advances in Oncology Treatment
Bispecific Antibodies Efficacious in Multiple Myeloma with Renal Impairment
Peer Insights on Once-Daily Weight Management Therapy at endo 2026
Obesity Management Improves Psoriatic Disease Outcomes
Subcutaneous Immunotherapy Offers Alternative Administration at ASCO 2026
Allogeneic Cell Therapy for EBV+ PTLD: EHA 2026 Insights
Early Breast Cancer at ASCO 2026: Trials to Watch
CAR T-Cell Therapy Guidelines Evolve for Lymphoma, Myeloma at EHA 2026
FLT3mut+ AML Outcomes: EHA 2026 Reviews Current Strategies
MRD Status Guides First-Line Treatment Duration in Haematologic Malignancies
ASCO 2026 May 30th Program Highlights: Immunotherapy Advances in Solid Tumors
NDMM Treatment Advances: Quadruplet Regimens Show Efficacy
Myelofibrosis Management: Cytopenia Guides Treatment at EHA 2026
Sarcoidosis: Current Understanding of Diagnosis and Management
Avapritinib Improves Outcomes in Nonadvanced and Advanced Systemic Mastocytosis
XLH Management: Rheumatology Must Adapt at EULAR 2026
Infection Prevention Critical in Hematological Malignancies
AI Foundation Models Enhance Diagnostic Insights in Oncology
Early SLE Disease Control: Targeting IFN Pathway at EULAR 2026
Doctor-Patient Communication Improves Treatment Acceptance in Cancer
Allogeneic Cell Therapy for EBV+ PTLD: EHA 2026 Insights
RA Treatment Optimisation: Applying Two Decades of Progress
FLT3 Inhibitors Improve AML Outcomes Pre- and Post-Transplant
CML Survivorship: Beyond Survival to Quality of Life
Classic CAH: New Approaches to Glucocorticoid Dosing
NDMM Treatment Optimisation: Communication Key to Individualisation
Immunological Insights Inform ILD & Transplant Outcomes
A-TANGO Score Refines ACLF Diagnosis, Prognosis in Cirrhosis
EULAR 2026: Polymyalgia Rheumatica Guidelines Incorporate RWE
ATS 2026: NTM Lung Disease Detection, Therapy, QoL Advancements
BTK Inhibitors in CLL: Evolving Landscape and Sequential Strategies
Endocrinologists' Role in Early Thyroid Eye Disease Recognition
AI in Hematology: EHA 2026 Focuses on Practical, Ethical Integration
SLE Pathophysiology Advances Inform Future Precision Care at EULAR 2026
Immuno-Fibrotic Crosstalk: A New Target in Rheumatology
Multimodal OSA Treatment: Nerve Stimulation, Surgery, Oral Appliances
Multidisciplinary Approach Improves Autoimmune ILD Management
Korlym® Improves Cushing's Syndrome Symptoms in Patient Experience Data
Desmopressin Dosing Refined for Central Diabetes Insipidus
AI, Wearables Transform Sleep Diagnostics: ATS 2026 Preview
Infection Prevention Critical in Hematological Malignancies
Optimising PsA and axSpA Treatment: EULAR 2026 Focuses on Early Intervention
Early Intervention Crucial for Inflammatory Joint Disease, Osteoporosis
CAR T Cell Therapy Shows Efficacy in Autoimmune Diseases at EULAR 2026
How Immunotherapy Unmasks Invisible Lung Cancer
Severe Hypoglycemia in T1D: Enhancing Patient-Clinician Dialogue
Hypercortisolism: Emerging Diagnostic and Management Insights
Evolving Infection Prevention in HSCT and Cellular Therapies
Triple Therapy Optimises COPD Outcomes at ATS 2026
Real-World Data Confirms Proximal Complement Inhibition in PNH
ASCO 2026 June 1st Program Highlights: Novel Immunotherapy Data
Acromegaly Management: Focus on Biochemical Control at ENDO 2026
ICI Dissemination Challenges Highlighted at ASCO 2026
ILD Diagnosis and Management: A Practical ATS 2026 Update
CD38 mAb Quad Therapy: Subcutaneous Dosing Reduces Burden
AI Algorithms Enhance Pulmonary Disease Management at ATS 2026
Macrophages: Dual Role in Haematological Malignancies Explored
BCMA-Directed Therapies Show Efficacy in Relapsed/Refractory Multiple Myeloma
NK Cell Immunotherapy: Biology to Clinic at AACR 2026
Biomarkers and Novel Treatments Highlight Prostate Cancer Advances at ASCO
JAK Inhibitor Combinations Show Efficacy in Myelofibrosis at EHA 2026
Immune Drivers in Autoimmune Cytopenias Inform Patient Care
Novel Biomarkers Improve Pediatric Solid Tumor Detection
ASCO 2026 May 31st Program Highlights: Focus on Novel Immunotherapies
Early ILD Recognition in SARD/SSc: Drivers of Progression and Workflow Solutions
Cancer Therapies Induce Lifespan Comorbidities: ACCR 2026 Review
SpA Remission: Clinical Symptoms vs. Subclinical Inflammation at EULAR 2026
Afirma Molecular Testing: Unique Situations and New Prognostic Development
DLBCL Relapse: EHA 2026 Addresses Gaps in Treatment Strategy
Autoantibodies: Hidden Drivers of Autoimmune Rheumatic Diseases
Pediatric Pulmonary Research Gaps Highlighted for Global Health
Acute Respiratory Failure: Lifespan Phenotypes and Trajectories
EASL 2026 Consensus: AATD-Liver Disease Management Standardised
EASL 2026: Non-invasive Diagnostics Advance Liver Disease Staging
EASL 2026 Forum: Enhancing Patient-Clinician Communication
HDV Management: EASL 2026 Highlights PegIFN-α as Standard
ITP Management: Bridging Clinician and Patient Perspectives
EASL 2026: Alcohol Policy Action Needed for Liver Disease
CAR T Cell Therapy Shows Promise in SLE and SSc Immune Reset
Novel Approaches Address Multiple Myeloma Resistance at EHA 2026
Novel Approaches in R/R MM: Expert Perspectives from EHA 2026
EULAR 2026: Earlier AxSpA Recognition Improves Disease Burden
YUTREPIA® (treprostinil) Inhalation Powder for PH-ILD Patients
Early AxSpA Diagnosis: Case-Based Discussion at EULAR 2026
Epithelial Dysfunction: A Unified Target in Airway Disease Management
JASCAYD® (nerandomilast) Offers New Therapeutic Option for COPD
Obesity Care: Tailored Treatment Strategies Highlighted at endo 2026
Low Alkaline Phosphatase: Recognizing Clinical Consequences
Lupus Management: Progress and Persistent Challenges at EULAR 2026
MCED Tests Show Promise for Earlier Cancer Detection at ASCO 2026
MLVs: Dual Role in Brain Metastases Offers Therapeutic Targets
Late-Onset Genetic Cholestasis: Underdiagnosis in Adults Examined
Rapid SLE Control Prevents Organ Damage: EULAR 2026 Focus
Inflammation Drives Sickle Cell Disease Pathophysiology
HER2-Expressing Breast Cancer: Advancements in Targeted Therapies
AI in Oncology: Practical Applications Transforming Cancer Care
Bispecific Antibodies Positioned in Relapsed Follicular Lymphoma
Defining Hyperphagia Treatment Possibilities in Prader-Willi Syndrome
Personalized Hemophilia Care: EHA 2026 Highlights Individualized Approaches
AML: Rethinking Intensive Therapy for Myelodysplasia-Related & Therapy-Related Subtypes
CPET Advances Refine Cardiopulmonary Disease Assessment at ATS 2026
Multiple Myeloma: Aligning Innovation with Clinical Practice at EHA 2026
IPF/PPF: Patient and Pulmonologist Perspectives Highlight Care Gaps
IDH1m AML: Ivosidenib Plus Azacitidine Improves OS by 12.5 Months
EULAR 2026: Psoriatic Disease Spectrum Highlights
Steroidogenesis Inhibitor Targets Root Cause of Cushing’s Syndrome
CD20-Targeted Therapies Remain Central to NHL Management
Multidisciplinary Care Improves Spondyloarthritis Outcomes
Pediatric Advanced Bronchoscopy: Precision in Airway Management
MASLD Diagnosis Faces Barriers Despite 2024 EASL Guidelines
TRUQAP + Fulvestrant: 2L Option for HR+/HER2- aBC/mBC with PI3K-AKT Alterations
CLL First-Line Treatment: BTK Inhibitors vs. Venetoclax Combinations
Cancer Care Disparities Highlighted in Crisis, Displaced Populations
AI Integration Improves Lung Cancer MDT Workflow at ATS 2026
PEAK Study Shows Novel Agent Improves PFS in Advanced GIST
AML: Fitness, Not Age, Predicts Intensive Chemotherapy Eligibility
DLBCL Treatment Sequencing: EHA 2026 Explores Current Therapies
Tile Radiation for Large Brain Mets: A New Approach at ASCO 2026
CAR T Therapy Shows Sustained Efficacy in Relapsed/Refractory Lymphoma
ATS 2026: Bronchiectasis and NTM Pulmonary Disease Management
Tafasitamab-R-CHOP Boosts Frontline DLBCL Outcomes at ASCO 2026
AATD: Aiming for AAT Restoration and Clinically Meaningful Endpoints
RA Care: Navigating Treatment Choices at EULAR 2026
Hypothyroidism: Symptom Burden Persists Despite Euthyroidism
Liver-Directed Treatment Shows Efficacy in Metabolic Dysfunction
12 Months of Romosozumab Builds Bone Density in Postmenopausal Osteoporosis
CAR T: Speed and Reliability Critical for Patient Outcomes
Cushing's Syndrome: Addressing Diagnostic Delays and Treatment Gaps
Desiccated Thyroid Extract: Efficacy and Safety in Hypothyroidism
Severe Asthma: Beyond Airway Focus in Treatment Decisions at ATS 2026
CELMoDs Show Promise in Relapsed/Refractory Multiple Myeloma
Optimising Transplant in Haemoglobinopathies: EHA 2026 Perspectives
Yoga Reduces Insomnia, Fatigue, Anxiety in Cancer Survivors
CLL First-Line Therapy: Case-Based Insights from EHA 2026
Belantamab Mafodotin's Evolving Role in RRMM: EHA 2026 Insights
Outsmarting Shape-Shifting Lung Cancer Resistance
CAR T in DLBCL: Optimising Patient Outcomes at EHA 2026
Tirzepatide: Efficacy in Weight Management Explored at ATS 2026
DNA Methylation Patterns Emerge as Sarcoma Biomarkers
Optimizing Frontline LR-MDS Treatment: EHA 2026 Data Review
Rare Conditions: EHA 2026 Highlights Diagnostic Challenges
GLP-1 RAs Reduce CV Risk in T2D Via Weight, Glucose Pathways
ANCA Vasculitis: Evolving Strategies Target Remission & Relapse Prevention
CLL: Aligning Patient Priorities with Targeted Therapy at EHA 2026
MASH Diagnosis: Non-Invasive Markers Show Promise at EASL 2026
AML Treatment Strategies: Optimising Outcomes in a Complex Disease
Few Pediatric Cancer Drugs Reach Phase 3 or Approval
AIRSUPRA® Reduces Asthma Exacerbations in ATS 2026 Data
Bispecific Antibodies Show Promise in Relapsed/Refractory Multiple Myeloma
Chemo-Free Therapy Improves Outcomes in Pediatric APL (EHA 2026)
Early Intervention in SLE/LN Reduces Long-Term Damage
Variceal Bleeding Management: EASL 2026 Skills Centre Focuses on Endoscopic and Pharmacological Strategies
Next-Gen Extracellular Vesicles: Biomarkers, Targets, Deliverables in Oncology
New 2L+ Combination Therapy Shows Efficacy in RRMM Post-PI/IMiD
Cancer Elimination at ASCO 2026: Aspirational Goals and Current Realities
EULAR 2026: Methotrexate Remains Cornerstone in RA First-Line
EASL Congress 2026: Key Trials to Watch in Liver Disease Management
More Breast Cancer Patients Can Skip Axillary Dissection
AAT Protein's Role in Lung Health Beyond COPD & Severe Asthma
HTAN Decodes Tumor Evolution: Ecological Perspective at AACR2026
Systemic Sclerosis: EULAR 2026 Highlights Diagnosis, Prognosis
Salivary Galectin-9 Elevated in Primary Sjögren's, Lacks Disease Activity Correlation
HYRNUO® (Sevabertinib) Shows Efficacy in Advanced Solid Tumours
Myriad's Precise MRD™ Test Shows Ultra-Sensitive Detection at ASCO 2026
EASL 2026: Liver and Spleen Elastography for Fibrosis Assessment
Oncodetect® MRD Test Shows Analytical Validity, Clinical Utility at ASCO
ATS 2026: Ultrasound Education Advances for Clinical Practice
XLH Adults: Osteomalacia Persists Despite Conventional Therapy
AML: Fitness, Not Age, Predicts IC Eligibility at EHA 2026
Molecular Hematology: From Gene Profiles to Therapy Profiles at EHA 2026
IKT-001 Adaptive Study Programme for Pulmonary Arterial Hypertension
DLBCL Management: Bispecific Antibodies as Emerging Therapeutic Option
Symptom Science Integration Improves Cancer Outcomes at ASCO 2026
Eosinophilic Disorders: Best Practices for HES and EGPA at ATS 2026
VEXAS Syndrome: Expert Consensus on Multidisciplinary Care at EULAR 2026
Endo 2026: Risk-Based Osteoporosis Management Refines Clinical Practice
EHA 2026: Anticipating Advances in Haematological Malignancies
New Biologic Offers Option for Severe Eosinophilic Asthma
RA Patients Face Elevated Fracture Risk: EULAR 2026 Highlights
CLL: EHA 2026 to Address Unmet Needs in Treatment Selection
ASCO 2026 May 29th Program Highlights: Novel Oncology Therapies
Iron Status Clarifies Erythrocytosis, Symptoms in Polycythemia Vera
Novel Therapies Improve Outcomes Post-cBTKi in CLL at EHA 2026
Radiopharmaceutical Therapy: Improving Effectiveness, Access, and Safety
EGPA: Early Recognition & Targeted Intervention Improve Outcomes
Inluriyo™ and Verzenio® Presentations at ASCO 2026
Sjögren’s Disease: Targeting Underlying Activity Beyond Symptoms
TACE + Camrelizumab/Rivoceranib Improves OS in Unresectable HCC
Hypoparathyroidism Treatment: Patient, Care Partner, HCP Perspectives
BRINSUPRI® First Therapy Approved for NCFB at ATS 2026
ATS 2026: Addressing the Cough Assessment Gap in Respiratory Disease
Epithelial Cytokines Link Severe Asthma, CRSwNP, COPD at ATS 2026
B-Cell Dysregulation Targeted Upstream in Primary Sjögren Disease
Triple Therapy in Asthma: Real-World Evidence Supports Earlier Use
EASL 2026: PSC Therapies Advance Beyond Symptom Management
Right Heart Catheterization: ATS 2026 Clarifies Waveform Interpretation
DLBCL Treatment: Emerging Targeted Therapies at EHA 2026
TLR7/8 Inhibition Offers New Lupus Perspective at EULAR 2026
Ventilator Management: Foundations for Bedside Implementation
IL-33's Dual Role in COPD: Inflammation and Mucus Dysfunction
Bispecific Antibodies in FL: EHA 2026 Explores Advancing Outcomes
Fixed-Duration BCL-2 Combo Offers Time Off Treatment in 1L CLL
Bronchoscopy Training: ATS 2026 Focuses on EBUS and Guided Techniques
Treat-to-Target in SLE: Balancing Burden, Benefit, and Risk
Contagion: Acute Respiratory Failure Cases Highlight Ventilator Management
ATS 2026: Lung Cancer Management Advances in Targeted Therapy
BCMA Bispecifics Transition to Community Myeloma Care: EHA 2026
Bispecific Antibodies Show Promise in Relapsed/Refractory Haematological Malignancies
MASH Advanced Fibrosis: Experts Detail Unique Challenges at EASL 2026
Immunotherapy and Targeted Therapy: New Data from ASCO 2026
MAVEs Inform Variant Interpretation in Clinical Oncology Practice
Caplacizumab Improves iTTP Outcomes in Real-World Settings
CD19+ B-Cell Targeting Shows Efficacy in IgG4-RD Management
ASCO 2026: Anticipating Advances in Oncology Treatment
Bispecific Antibodies Efficacious in Multiple Myeloma with Renal Impairment
Peer Insights on Once-Daily Weight Management Therapy at endo 2026
Obesity Management Improves Psoriatic Disease Outcomes
Subcutaneous Immunotherapy Offers Alternative Administration at ASCO 2026
Allogeneic Cell Therapy for EBV+ PTLD: EHA 2026 Insights
Early Breast Cancer at ASCO 2026: Trials to Watch
CAR T-Cell Therapy Guidelines Evolve for Lymphoma, Myeloma at EHA 2026
FLT3mut+ AML Outcomes: EHA 2026 Reviews Current Strategies
MRD Status Guides First-Line Treatment Duration in Haematologic Malignancies
ASCO 2026 May 30th Program Highlights: Immunotherapy Advances in Solid Tumors
NDMM Treatment Advances: Quadruplet Regimens Show Efficacy
Myelofibrosis Management: Cytopenia Guides Treatment at EHA 2026
Sarcoidosis: Current Understanding of Diagnosis and Management
Avapritinib Improves Outcomes in Nonadvanced and Advanced Systemic Mastocytosis
XLH Management: Rheumatology Must Adapt at EULAR 2026
Infection Prevention Critical in Hematological Malignancies
AI Foundation Models Enhance Diagnostic Insights in Oncology
Early SLE Disease Control: Targeting IFN Pathway at EULAR 2026
Doctor-Patient Communication Improves Treatment Acceptance in Cancer
Allogeneic Cell Therapy for EBV+ PTLD: EHA 2026 Insights
RA Treatment Optimisation: Applying Two Decades of Progress
FLT3 Inhibitors Improve AML Outcomes Pre- and Post-Transplant
CML Survivorship: Beyond Survival to Quality of Life
Classic CAH: New Approaches to Glucocorticoid Dosing
NDMM Treatment Optimisation: Communication Key to Individualisation
Immunological Insights Inform ILD & Transplant Outcomes
